Mental Health or Cardiac Health. Is there a reason to choose? Cardiac arrhythmias induced by Atomoxetine and Methylphenidate
The current treatment of Attention Deficit Disorder and Attention Deficit with Hyperactivity consists mainly in the administration of Straterra (Atomoxetine) Concerta and Ritalin (Methylphenidate). The FDA warned that the products might increase systolic, diastolic blood pressure, and lead to ve...
Saved in:
| Main Authors: | Gabriel Cismaru, Viorel Lupu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Journal of Mind and Medical Sciences |
| Subjects: | |
| Online Access: | https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1287&context=jmms |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CytochromeP450 2D6 and Atomoxetine Metabolism
by: J Gordon Millichap
Published: (2010-10-01) -
Off-label use of atomoxetine in adults: is it safe?
by: Peter Silverstone, et al.
Published: (2012-07-01) -
Diabetes mellitus and cardiac arrhythmias
by: L. Yu. Morgunov
Published: (2024-04-01) -
Detection of atomoxetine and its metabolites in the urine by thin-layer chromatography and mass spectrometry
by: S. A. Karpushyna, et al.
Published: (2022-03-01) -
Psychopathological features of anxiety disorders in patients with cardiac arrhythmias before and after cardiac pacemaker implantation
by: B. G. Iskenderov, et al.
Published: (2008-12-01)